Pretty encouraging results from ESMO. Adding a personalized mRNA vaccine to immunotherapy reduced the risk of melanoma recurrence or death by 42%. Still waiting on peer-reviewed results and longer follow-up, but this could be a big development for cancer treatment. Source: https://www.oncologynewscentral.com/melanoma-and-skin-cancer/personalized-mrna-vaccine-reduces-melanoma-recurrence-risk   submitted by   /u/Postcall_Dogtor [link]   [comments]